Hiring of Gemma Colomer as counsel will allow Cuatrecasas to strengthen its lead position in life sciences and healthcare sector
Don’t miss our content
SubscribeCuatrecasas has strengthened its leading position in the life sciences and healthcare sector by hiring Gemma Colomer as a new counsel specializing in pharmaceutical and healthcare regulatory law. Her solid professional background will add value to the firm's specialty group and to a practice area under permanent development.
After over 23 years of experience in the pharmaceutical and healthcare technology industry, Gemma Colomer stands out for her expertise in regulatory affairs, her technical competence, and extensive experience and knowledge of the life sciences sector. With her proven track record, she provides comprehensive advice to clients in the sector, ranging from assistance with regulatory and contractual law, and sectoral compliance, to regulatory disputes, and administrative and litigation proceedings in court.
Gemma Colomer has extensive experience teaching in leading master programs, including the Master in the Pharmaceutical and Biotechnology Industry at Universitat Pompeu Fabra (Barcelona) and the Course in Pharmaceutical Law at the Barcelona Bar Association. She also contributes to publications and prestigious international events.
On becoming part of the firm, she commented: "I am joining Cuatrecasas with the aim of contributing my technical and practical experience to boost the Life Sciences and Healthcare practice area, and offer the specialized advice required by companies in a highly regulated sector that is currently facing significant challenges."
The new counsel will play an essential role in strengthening and increasing the multidisciplinary nature of the specialty group in one of the most regulated sectors of the market, that of life sciences and healthcare. With this appointment, Cuatrecasas reaffirms its strong commitment to continue leading the way in providing comprehensive advisory services to the pharmaceutical and healthcare technology industry.
Don’t miss our content
Subscribe